Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries

Heart Lung and Circulation

Volumn 18, Issue 3, 2009, Pages 184-190

  Yan, Bryan P ^a   Clark, David J ^b   Buxton, Brian ^e   Ajani, Andrew E ^c,h,i   Smith, Julian A ^f   Duffy, Stephen J ^d   Shardey, Gil C ^f   Skillington, Peter D ^e   Farouque, Omar ^b   Yii, Michael ^g   Yap, Cheng Hon ^e   Andrianopoulos, Nick ^h   Brennan, Angela ^h   Dinh, Diem ^h   Reid, Christopher M ^h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Departments of Cardiology   (Australia)

^c Departments of Cardiology   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e Department of Cardiothoracic Surgery ^*  (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

^g St Vincent Hospitals   (Australia)

^h MONASH UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Coronary artery bypass surgery; Percutaneous coronary intervention

Indexed keywords

ACUTE HEART INFARCTION; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; BARE METAL STENT; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; KIDNEY FAILURE; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK FACTOR; SEX DIFFERENCE; STENT THROMBOSIS; SURVIVAL; TREATMENT INDICATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AUSTRALIA; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; SEX FACTORS;

EID: 67349227099     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2008.10.005     Document Type: Article

References (16)

1. Yusuf S., Zucker D., Peduzzi P., Fisher L.D., Takaro T., Kennedy J.W., Davis K., Killip T., Passamani E., and Norris R. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 8922 (1994) 563-570
2. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neill W.W., Schaff H.V., Whitlow P.L., Williams D.O., Antman E.M., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., and Riegel B. ACC/AHA task force on practice guidelines; ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Circulation 113 1 (2006) 156-175
3. Serruys P.W., Unger F., Sousa J.E., Jatene A., Bonnier H.J., Schonberger J.P., Buller N., Bonser R., van den Brand M.J., van Herwerden L.A., Morel M.A., van Hout B.A., and Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 15 (2001) 1117-1124
4. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 360 Sep (9338) (2002) 965-970
5. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 14 (2003) 1315-1323
6. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 3 (2004) 221-231
7. Win H.K., Caldera A.E., Maresh K., Lopez J., Rihal C.S., Parikh M.A., Granada J.F., Marulkar S., Nassif D., Cohen D.J., Kleiman N.S., and EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 18 (2007) 2001-2009
8. Reid C.M., Rockell M., Skillington P.D., Shardey G.C., Smith J.A., Yii M., Seevanayagam S., Mohajeri M., and Rowland M. Initial twelve months experience and analysis for 2001-2002 from the Australasian Society of Cardiac and Thoracic Surgeons-Victorian database project. Heart Lung Circ 13 3 (2004) 291-297
9. Ajani A.E., Szto G., Duffy S.J., Eccleston D., Clark D.J., Lefkovits J., Chew D.P., Warren R., Black A., New G., Walton A., Lew R., Shaw J., Horrigan M., Sebastian M., Yan B.P., Brennan A., Meehan A., Reid C., Krum H., and Melbourne Interventional Group investigators. The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ 15 1 (2006) 44-47
10. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., Mullany C.J., Ornato J.P., Pearle D.L., Sloan M.A., and Smith Jr. S.C. American College of Cardiology; American Heart Association; Canadian Cardiovascular Society ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. J Am Coll Cardiol 44 3 (2004) 671-719
11. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 9351 (2003) 13-20
12. Lee D.C., Oz M.C., Weinberg A.D., and Ting W. Appropriate timing of surgical intervention after transmural acute myocardial infarction. J Thorac Cardiovasc Surg 125 1 (2003) 115-119
13. Hannan E.L., Michael R., Holmes D.R., King III S.B., Gary W., Ambrose J.A., Samin S., Stanley K., Clark L.T., and Jones R.H. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 113 (2006) 2406-2412
14. Babapulle M.N., Joseph L., Belisle P., Brophy J.M., and Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364 9434 (2004) 583-591
15. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabate M., Suttorp M.J., Baumgart D., Seyfarth M., Pfisterer M.E., and Schomig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 10 (2007) 1030-1039
16. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., and Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 17 (2005) 2126-2130